PD-1/PD-L1 inhibitors can specifically bind to PD-L1 on tumor cells to inhibit its expression so that the function of the suppressed T cells can recover the recognition function of tumor cells so as to achieve an anti-cancer effect through the body’s own immune system [19]. Here, PDCD1 is linked to neoplasm.